BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 6602180)

  • 1. The ability of lymphokine and lipopolysaccharide to induce procoagulant activity in mouse macrophage cell lines.
    Farram E; Geczy CL; Moon DK; Hopper K
    J Immunol; 1983 Jun; 130(6):2750-6. PubMed ID: 6602180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage procoagulant activity as a measure of cell-mediated immunity in the mouse.
    Geczy CL; Farram E; Moon DK; Meyer PA; McKenzie IF
    J Immunol; 1983 Jun; 130(6):2743-9. PubMed ID: 6189899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal analysis of mechanisms of murine T helper cell collaboration with effector cells of macrophage lineage.
    Fan ST; Edgington TS
    J Immunol; 1988 Sep; 141(6):1819-27. PubMed ID: 2971715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for effects of interleukin 4 (B cell stimulatory factor 1) on macrophages: enhancement of antigen presenting ability of bone marrow-derived macrophages.
    Zlotnik A; Fischer M; Roehm N; Zipori D
    J Immunol; 1987 Jun; 138(12):4275-9. PubMed ID: 3495588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines.
    Thomson AW; Moon DK; Geczy CL; Nelson DS
    Immunology; 1983 Feb; 48(2):291-9. PubMed ID: 6337088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicity.
    Kern DE; Grabstein KH; Okuno K; Schreiber RD; Greenberg PD
    J Immunol; 1989 Dec; 143(12):4308-16. PubMed ID: 2687379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities.
    Kelso A; Glasebrook AL; Kanagawa O; Brunner KT
    J Immunol; 1982 Aug; 129(2):550-6. PubMed ID: 7045227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of monocyte-macrophage procoagulant activity by transformed cell lines.
    Rambaldi A; Alessio G; Casali B; Passerini CG; Donati MB; Mantovani A; Semeraro N
    J Immunol; 1986 May; 136(10):3848-55. PubMed ID: 3701063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotaxis by mouse macrophage cell lines.
    Aksamit RR; Falk W; Leonard EJ
    J Immunol; 1981 Jun; 126(6):2194-9. PubMed ID: 7229371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of tumour carriage on the production of lymphokines affecting macrophage behaviour.
    McIntosh LC; Morrice LM; Udagawa Y; Thomson AW
    Immunology; 1986 Mar; 57(3):359-65. PubMed ID: 3485563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte procoagulant inducing factor: a lymphokine involved in the T cell-instructed monocyte procoagulant response to antigen.
    Gregory SA; Kornbluth RS; Helin H; Remold HG; Edgington TS
    J Immunol; 1986 Nov; 137(10):3231-9. PubMed ID: 2945864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and purification of mouse macrophage procoagulant-inducing factor.
    Ryan J; Geczy CL
    J Immunol; 1986 Nov; 137(9):2864-70. PubMed ID: 3760575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mechanism of migration inhibition in delayed-type hypersensitivity reactions. II. Lymphokines promote procoagulant activity of macrophages in vitro.
    Geczy CL; Hopper KE
    J Immunol; 1981 Mar; 126(3):1059-65. PubMed ID: 7462626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the gamma-interferon-mediated induction of antigen-presenting ability in P388D1 cells.
    Zlotnik A; Shimonkevitz RP; Gefter ML; Kappler J; Marrack P
    J Immunol; 1983 Dec; 131(6):2814-20. PubMed ID: 6196401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional heterogeneity of culture-grown bone marrow-derived macrophages. II. Lymphokine stimulation of antigen-presenting function.
    Lee KC; Wong M
    J Immunol; 1982 Jun; 128(6):2487-92. PubMed ID: 6978905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage activation to kill Leishmania tropica: characterization of a T cell-derived factor that suppresses lymphokine-induced intracellular destruction of amastigotes.
    Nacy CA
    J Immunol; 1984 Jul; 133(1):448-53. PubMed ID: 6202789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in antibody-dependent cellular cytotoxicity and activated killing of tumor cells by macrophage cell lines.
    Ralph P; Nakoinz I
    Cancer Res; 1981 Sep; 41(9 Pt 1):3546-50. PubMed ID: 6973392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pertussigen in vivo enhances antigen-specific production in vitro of lymphokine that stimulates macrophage procoagulant activity and plasminogen activator.
    de Moerloose PA; Hamilton JA; Sewell WA; Vadas MA; Mackay IR
    J Immunol; 1986 Dec; 137(11):3528-33. PubMed ID: 3782790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide.
    Pace JL; Russell SW
    J Immunol; 1981 May; 126(5):1863-7. PubMed ID: 7217671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the activation of mouse bone marrow-derived macrophages by the macrophage cytotoxicity factor (MCF).
    Meerpohl HG; Lohmann-Matthes ML; Fischer H
    Eur J Immunol; 1976 Mar; 6(3):213-7. PubMed ID: 1086777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.